Neo-Penotran Forte Vaginal Suppository for Vaginal Trichomoniasis
NCT ID: NCT01361048
Last Updated: 2018-01-19
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
40 participants
INTERVENTIONAL
2011-12-31
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tolerability and Pharmacokinetic Study of Econazole Nitrate Plus Benzydamine HCl Vaginal Pessary
NCT02720783
A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious Vaginosis
NCT01867164
A Randomized Study Evaluating the Therapeutic Equivalence of Two Butoconazole Nitrate Vaginal Cream, 2% Formulations
NCT01039584
Tolerability and Pharmacokinetic Study of Econazole Nitrate and Benzydamine HCl Intravaginal Cream
NCT02713893
Efficacy and Safety of the Association of Clotrimazole and Metronidazole in the Treatment of Vaginal Discharge From Different Etiologies.
NCT02713139
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
oral metronidazole
control arm
oral metronidazole
2 gm oral once
neo penotran forte
neo penotran forte vaginal suppository twice a day for 7 days
neo penotran forte
neo penotran forte intravaginal twice a day for 7 days
neo penotran forte once a day
neo penotran forte vaginal suppository once a day for 7 days
neo penotran forte once a day
neo penotran forte intravaginally once a day for 7 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
oral metronidazole
2 gm oral once
neo penotran forte
neo penotran forte intravaginal twice a day for 7 days
neo penotran forte once a day
neo penotran forte intravaginally once a day for 7 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* known immunodeficiency
* allergy to study drugs
* concurrent yeast infection
* history of seizures or peripheral neuropathy
* unwillingness to abstain from alcohol during treatment period and for 48 hrs after concurrent lithium
* anticoagulation therapy, and abuse
* patient expected to have menses within 8 days of enrollment
19 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Embil Pharmaceutical Co. Ltd
INDUSTRY
University of Alabama at Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jane Schwebke
Professor of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Personal Health Clinic UAB
Birmingham, Alabama, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TV-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.